Search

Author/Creator Jansen, M. Subject 616.1572005

3. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study. (23rd July 2015)

Authors:
Kreuz, W.; Escuriola Ettingshausen, C.; Vdovin, V.; Zozulya, N.; Plyushch, O.; Svirin, P.; Andreeva, T.; Bubanská, E.; Campos, M.; Benedik‐Dolničar, M.; Jiménez‐Yuste, V.; Kitanovski, L.; Klukowska, A.; Momot, A.; Osmulskaya, N.; Prieto, M.; Šalek, S. Z.; Velasco, F.; Pavlova, A.; Oldenburg, J.
Journal:
Haemophilia
Issue:
Volume 22:Number 1(2016:Jan.)
Page Start:
87
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Immunogenicity, efficacy and safety of Nuwiq® (human‐cl rhFVIII) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect Study. Issue 2 (16th August 2017)

Authors:
Liesner, R. J.; Abashidze, M.; Aleinikova, O.; Altisent, C.; Belletrutti, M. J.; Borel‐Derlon, A.; Carcao, M.; Chambost, H.; Chan, A. K. C.; Dubey, L.; Ducore, J.; Fouzia, N. A.; Gattens, M.; Gruel, Y.; Guillet, B.; Kavardakova, N.; El Khorassani, M.; Klukowska, A.; Lambert, T.; Lohade, S.
Journal:
Haemophilia
Issue:
Volume 24:Issue 2(2018)
Page Start:
211
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate®: Final report from a prospective study. Issue 2 (3rd January 2018)

Authors:
Klukowska, A.; Komrska, V.; Vdovin, V.; Pavlova, A.; Jansen, M.; Lowndes, S.; Belyanskaya, L.; Walter, O.; Laguna, P.
Journal:
Haemophilia
Issue:
Volume 24:Issue 2(2018)
Page Start:
221
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗